Reducing FX volatility and improving financial results

In this second webinar from Pfizer, our Treasury Team of the Year, Mark Hopkins will tell us more about Pfizer’s hedging strategy. With over 60% of its revenues denominated in non USD currency swings can have a big impact on Pfizer’s financial results. The new programme Pfizer is implementing has reduced the spot rate volatility of currency pairs by over 30% and the net earnings exposure to currencies in the programme by over 50%.